Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.
The Biotechnology industry has on average risen 41.3% over the last 3 months. The average price/earnings ratio is 66.8 and the average return on equity is 108.6%. These averages are based on an equal weighting of the 394 most liquid stocks in this industry.
Symbol | Company Name | Setup | TA | FA | CRS | % Chg | 1 Month | 3 Month | 6 Month | PE | Market Cap | Vol(50) | Action |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 69.4 | -0.85% | 6.67% | 14.27% | 3.1% | 20.62 | 385.71B | 5.01M | ||||
| AMGN | AMGEN INC | 15.14 | -2.24% | -4.79% | -6.38% | -11.9% | 12.67 | 148.80B | 1.98M | ||||
| GILD | GILEAD SCIENCES INC | 79.65 | -2.81% | -3.76% | 4.16% | 2.79% | 14.8 | 142.13B | 6.08M | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | 12.12 | -0.71% | 1.08% | -13.38% | -21.84% | 23.29 | 101.15B | 1.72M | ||||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 93.41 | -0.57% | 5.23% | 51.27% | 92.71% | N/A | 61.07B | 1.16M | ||||
| REGN | REGENERON PHARMACEUTICALS | 9.05 | -1.44% | -1.05% | 5.81% | -16.03% | 12.27 | 59.35B | 954.98K | ||||
| ARGX | ARGENX SE - ADR | 87.18 | -0.94% | 15.93% | 30.89% | 25.03% | 81.59 | 46.29B | 404.07K | ||||
| ONC | BEONE MEDICINES LTD-ADR | 0 | -3.38% | 4.73% | 20.29% | 25.14% | 5.67 | 38.56B | 390.87K | ||||
| INSM | INSMED INC | 94.4 | 0.1% | 14.23% | 47.81% | 90.63% | N/A | 30.85B | 2.64M | ||||
| BNTX | BIONTECH SE-ADR | 12.44 | -7.26% | -14.16% | -9.22% | -2.74% | N/A | 23.26B | 833.24K | ||||
| NTRA | NATERA INC | 76.1 | -3.05% | 6.36% | 1.92% | 13.69% | N/A | 23.13B | 1.30M | ||||
| BIIB | BIOGEN INC | 18.35 | -2.67% | 7.35% | 10.88% | 3.89% | 9.05 | 21.24B | 1.45M | ||||
| UTHR | UNITED THERAPEUTICS CORP | 85.41 | 0.04% | 29.79% | 42.94% | 31.83% | 15.81 | 18.32B | 714.32K | ||||
| GMAB | GENMAB A/S -SP ADR | 67.92 | -2.76% | 21.06% | 21.91% | 35.64% | 7.26 | 17.11B | 1.25M | ||||
| INCY | INCYTE CORP | 83.37 | -3.56% | -3.55% | 22.66% | 22.46% | 15.89 | 16.23B | 1.71M | ||||
| NBIX | NEUROCRINE BIOSCIENCES INC | 72.62 | -1.2% | 8.04% | 14.05% | 28.1% | 41.97 | 14.07B | 871.88K | ||||
| SMMT | SUMMIT THERAPEUTICS INC | 9.18 | 1.83% | -28.39% | -4.25% | -8.9% | N/A | 14.07B | 3.84M | ||||
| ASND | ASCENDIS PHARMA A/S - ADR | 88.34 | -1.06% | 1.84% | 14.51% | 27.85% | N/A | 11.83B | 477.78K | ||||
| EXEL | EXELIXIS INC | 79.46 | 0.2% | 1.77% | -5.87% | 6.82% | 18.82 | 10.54B | 3.06M | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | 10.12 | -3.26% | -6.74% | -3.79% | -22.11% | 16.05 | 10.39B | 2.05M |